Naxitamab
Naxitamab (Hu3F8) is a humanized monoclonal antibody targeting the disialoganglioside GD2. Naxitamab can be used in research of neuroblastoma, osteosarcoma and other GD2-positive cancers.
Read more
€0.00
(tax incl.)
Reference:
HY-P99206
Brand: